BamSEC and AlphaSense Join Forces
Learn More

Milestone Pharmaceuticals Inc.

NASDAQ: MIST    
Share price (1/6/25): $2.19    
Market cap (1/6/25): $117 million

Material Contracts Filter

EX-10.1
from 10-Q 2 pages Milestone Pharmaceuticals Inc. Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 8-K 13 pages Cooperation Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Milestone Pharmaceuticals Inc. Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.2
from 10-Q 2 pages Milestone Pharmaceuticals Inc. Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 10-Q 7 pages First Amendment to Note Purchase Agreement ​
12/34/56
EX-10.2
from 8-K 99 pages Note Purchase Agreement
12/34/56
EX-10.1
from 8-K 64 pages Purchase and Sale Agreement by and Between Milestone Pharmaceuticals Inc. and Rtw Royalty I Dac Dated as of [●], 2023
12/34/56
EX-10.19
from 10-K 2 pages Milestone Pharmaceuticals Inc. Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.18
from 10-K 9 pages Consulting Agreement
12/34/56
EX-10.1
from 8-K 17 pages Exchange Agreement
12/34/56
EX-10.1
from 10-Q 20 pages 2019 Equity Incentive Plan
12/34/56
EX-10.1
from 8-K 23 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 57 pages License and Collaboration Agreement
12/34/56
EX-10.2
from S-3 9 pages Milestone Pharmaceuticals Inc. Form of Pre-Funded Warrant to Purchase Common Shares
12/34/56
EX-10.1
from S-3 27 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Milestone Pharmaceuticals Inc. ​ Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.3
from 10-Q 2 pages Milestone Pharmaceuticals Inc. ​ Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 8-K 39 pages Open Market Sale Agreementsm
12/34/56
EX-10.1
from 8-K 26 pages Securities Purchase Agreement
12/34/56
EX-10.3
from 8-K 5 pages Amending Agreement
12/34/56